The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of steroid use among patients with renal cell carcinoma (RCC) who develop immune-related adverse events (irAE).
 
Peter Zang
No Relationships to Disclose
 
Karen Resnick
No Relationships to Disclose
 
Travis Larsen
No Relationships to Disclose
 
Shirley Ye
No Relationships to Disclose
 
April Choi
No Relationships to Disclose
 
Xiao Yu
Stock and Other Ownership Interests - Neoleukin Therapeutics
Patents, Royalties, Other Intellectual Property - Neoleukin Therapeutics
 
Kevin Brady
No Relationships to Disclose
 
Varsha Tulpule
No Relationships to Disclose
 
Anishka D'souza
Honoraria - Dova Pharmaceuticals
 
Gino Kim In
Honoraria - Array BioPharma/Pfizer; Bristol-Myers Squibb; regeneron
Consulting or Advisory Role - Bristol-Myers Squibb; Castle Biosciences; Novartis; Sanofi
Speakers' Bureau - Merck; Regeneron; Rockpointe CME; Targeted Oncology
Research Funding - Checkmate Pharmaceuticals (Inst); Idera (Inst); Instil Bio (Inst); Regeneron (Inst); Replimune (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Regeneron